Functional evidence that Drosha overexpression in cervical squamous cell carcinoma affects cell phenotype and microRNA profiles

Although gain of chromosome 5p is one of the most frequent DNA copy‐number imbalances in cervical squamous cell carcinoma (SCC), the genes that drive its selection remain poorly understood. In a previous cross‐sectional clinical study, we showed that the microRNA processor Drosha (located on chromosome 5p) demonstrates frequent copy‐number gain and overexpression in cervical SCC, associated with altered microRNA profiles. Here, we have conducted gene depletion/overexpression experiments to demonstrate the functional significance of up‐regulated Drosha in cervical SCC cells. Drosha depletion by RNA interference (RNAi) produced significant, specific reductions in cell motility/invasiveness in vitro, with a silent RNAi‐resistant Drosha mutation providing phenotype rescue. Unsupervised hierarchical clustering following global profiling of 319 microRNAs in 18 cervical SCC cell line specimens generated two groups according to Drosha expression levels. Altering Drosha levels in individual SCC lines changed the group into which the cells clustered, with gene depletion effects being rescued by the RNAi‐resistant mutation. Forty‐five microRNAs showed significant differential expression between the groups, including four of 14 that were differentially expressed in association with Drosha levels in clinical samples. miR‐31 up‐regulation in Drosha‐overexpressing samples/cell lines was the highest‐ranked change (by adjusted p value) in both analyses, an observation validated by northern blotting. These functional data support the role of Drosha as an oncogene in cervical SCC, by affecting expression of cancer‐associated microRNAs that have the potential to regulate numerous protein‐coding genes. Copyright © 2011 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

[1]  Anton J. Enright,et al.  The two most common histological subtypes of malignant germ cell tumour are distinguished by global microRNA profiles, associated with differential transcription factor expression , 2010, Molecular Cancer.

[2]  T. Kalina,et al.  Aberrantly expressed CEACAM6 is involved in the signaling leading to apoptosis of acute lymphoblastic leukemia cells. , 2010, Experimental hematology.

[3]  Tao Jiang,et al.  The role of microRNA in human lung squamous cell carcinoma. , 2010, Cancer genetics and cytogenetics.

[4]  R. Gutzmer,et al.  MicroRNA‐15b represents an independent prognostic parameter and is correlated with tumor cell proliferation and apoptosis in malignant melanoma , 2010, International journal of cancer.

[5]  Jianjun Chen,et al.  MicroRNAs expression signatures are associated with lineage and survival in acute leukemias. , 2010, Blood cells, molecules & diseases.

[6]  Wei Shi,et al.  Comprehensive MicroRNA Profiling for Head and Neck Squamous Cell Carcinomas , 2010, Clinical Cancer Research.

[7]  Gabriele Sales,et al.  Identification of microRNA expression patterns and definition of a microRNA/mRNA regulatory network in distinct molecular groups of multiple myeloma. , 2009, Blood.

[8]  Wim Timens,et al.  Genomic aberrations in squamous cell lung carcinoma related to lymph node or distant metastasis. , 2009, Lung cancer.

[9]  Robert A. Weinberg,et al.  A Pleiotropically Acting MicroRNA, miR-31, Inhibits Breast Cancer Metastasis , 2009 .

[10]  Zugen Chen,et al.  MicroRNA Profiling and Head and Neck Cancer , 2009, Comparative and functional genomics.

[11]  K. Mimori,et al.  Over- and under-expressed microRNAs in human colorectal cancer. , 2009, International journal of oncology.

[12]  Zongguang Zhou,et al.  Clinicopathological Significance of microRNA-31, -143 and -145 Expression in Colorectal Cancer , 2009, Disease markers.

[13]  G. Smyth,et al.  Microarray background correction: maximum likelihood estimation for the normal–exponential convolution , 2008, Biostatistics.

[14]  M. Stanley,et al.  Characterization of naturally occurring HPV16 integration sites isolated from cervical keratinocytes under noncompetitive conditions. , 2008, Cancer research.

[15]  M. Mansukhani,et al.  Integrative genomics analysis of chromosome 5p gain in cervical cancer reveals target over-expressed genes, including Drosha , 2008, Molecular Cancer.

[16]  S. Tavaré,et al.  Pediatric malignant germ cell tumors show characteristic transcriptome profiles. , 2008, Cancer research.

[17]  William Ignace Wei,et al.  Mature miR-184 as Potential Oncogenic microRNA of Squamous Cell Carcinoma of Tongue , 2008, Clinical Cancer Research.

[18]  Li Mao,et al.  Transcriptomic dissection of tongue squamous cell carcinoma , 2008, BMC Genomics.

[19]  R. Vyzula,et al.  Altered Expression of miR-21, miR-31, miR-143 and miR-145 Is Related to Clinicopathologic Features of Colorectal Cancer , 2008, Oncology.

[20]  S. Grando,et al.  Overexpression of SLURP-1 and -2 alleviates the tumorigenic action of tobacco-derived nitrosamine on immortalized oral epithelial cells. , 2007, Biochemical pharmacology.

[21]  T. Kodama,et al.  Expression of androgen receptor through androgen-converting enzymes is associated with biological aggressiveness in prostate cancer , 2007, Journal of Clinical Pathology.

[22]  Leonard D. Goldstein,et al.  Global microRNA profiles in cervical squamous cell carcinoma depend on Drosha expression levels , 2007, The Journal of pathology.

[23]  N. Coleman,et al.  Gain and overexpression of the oncostatin M receptor occur frequently in cervical squamous cell carcinoma and are associated with adverse clinical outcome , 2007, The Journal of pathology.

[24]  Ekaterina S Jordanova,et al.  Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex genetic alterations in cervical cancer , 2007, BMC Genomics.

[25]  Y. Fujii,et al.  RNASEN Regulates Cell Proliferation and Affects Survival in Esophageal Cancer Patients , 2006, Clinical Cancer Research.

[26]  A. Teschendorff,et al.  Interferon-beta treatment of cervical keratinocytes naturally infected with human papillomavirus 16 episomes promotes rapid reduction in episome numbers and emergence of latent integrants. , 2006, Carcinogenesis.

[27]  Stefano Volinia,et al.  MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  Nicholas Coleman,et al.  Defining ploidy-specific thresholds in array comparative genomic hybridization to improve the sensitivity of detection of single copy alterations in cell lines. , 2006, The Journal of molecular diagnostics : JMD.

[29]  X. Agirre,et al.  Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues , 2006, Molecular Cancer.

[30]  M. Stanley,et al.  Selection of cervical keratinocytes containing integrated HPV16 associates with episome loss and an endogenous antiviral response. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[31]  Anastasia Khvorova,et al.  3′ UTR seed matches, but not overall identity, are associated with RNAi off-targets , 2006, Nature Methods.

[32]  T. Golub,et al.  Increased expression of genes converting adrenal androgens to testosterone in androgen-independent prostate cancer. , 2006, Cancer research.

[33]  B. Gusterson,et al.  Involvement of axonal guidance proteins and their signaling partners in the developing mouse mammary gland , 2006, Journal of cellular physiology.

[34]  Minchen Chien,et al.  Prognostic Values of microRNAs in Colorectal Cancer , 2006, Biomarker insights.

[35]  Bradley P. Coe,et al.  High‐resolution chromosome arm 5p array CGH analysis of small cell lung carcinoma cell lines , 2005, Genes, chromosomes & cancer.

[36]  C. Burge,et al.  Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA Targets , 2005, Cell.

[37]  M. Stanley,et al.  Genomic imbalances in 70 snap-frozen cervical squamous intraepithelial lesions: associations with lesion grade, state of the HPV16 E2 gene and clinical outcome , 2004, British Journal of Cancer.

[38]  Jean YH Yang,et al.  Bioconductor: open software development for computational biology and bioinformatics , 2004, Genome Biology.

[39]  G. Sauter,et al.  TRIO amplification and abundant mRNA expression is associated with invasive tumor growth and rapid tumor cell proliferation in urinary bladder cancer. , 2004, The American journal of pathology.

[40]  J. Wiebe,et al.  Expression of progesterone metabolizing enzyme genes (AKR1C1, AKR1C2, AKR1C3, SRD5A1, SRD5A2) is altered in human breast carcinoma , 2004, BMC Cancer.

[41]  Rafael A. Irizarry,et al.  Stochastic models inspired by hybridization theory for short oligonucleotide arrays , 2004, J. Comput. Biol..

[42]  David I. Smith,et al.  Acquisition of High-Level Chromosomal Instability Is Associated with Integration of Human Papillomavirus Type 16 in Cervical Keratinocytes , 2004, Cancer Research.

[43]  Gordon K Smyth,et al.  Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray Experiments , 2004, Statistical applications in genetics and molecular biology.

[44]  G. Yousef,et al.  Kallikrein gene downregulation in breast cancer , 2004, British Journal of Cancer.

[45]  Chi-Hung Lin,et al.  Genotypic analysis of esophageal squamous cell carcinoma by molecular cytogenetics and real-time quantitative polymerase chain reaction. , 2003, International journal of oncology.

[46]  Rafael A Irizarry,et al.  Exploration, normalization, and summaries of high density oligonucleotide array probe level data. , 2003, Biostatistics.

[47]  Martin Vingron,et al.  Variance stabilization applied to microarray data calibration and to the quantification of differential expression , 2002, ISMB.

[48]  T. Lister,et al.  Assignment1 of brain acid-soluble protein 1 (BASP1) to human chromosome 5p15.1→p14, differential expression in human cancer cell lines as a result of alterations in gene dosage , 2000, Cytogenetic and Genome Research.

[49]  P. Caroni,et al.  Shared and Unique Roles of Cap23 and Gap43 in Actin Regulation, Neurite Outgrowth, and Anatomical Plasticity , 2000, The Journal of cell biology.

[50]  N. Beauchemin,et al.  cis-Determinants in the cytoplasmic domain of CEACAM1 responsible for its tumor inhibitory function , 1999, Oncogene.

[51]  D. Russell,et al.  The parturition defect in steroid 5alpha-reductase type 1 knockout mice is due to impaired cervical ripening. , 1999, Molecular endocrinology.

[52]  N. Hayashi,et al.  Identification of the Calmodulin-binding Domain of Neuron-specific Protein Kinase C Substrate Protein CAP-22/NAP-22 , 1999, The Journal of Biological Chemistry.

[53]  E. Schröck,et al.  Advanced‐stage cervical carcinomas are defined by a recurrent pattern of chromosomal aberrations revealing high genetic instability and a consistent gain of chromosome arm 3q , 1997, Genes, chromosomes & cancer.

[54]  N. B. Atkin,et al.  Cytogenetics of carcinoma of the cervix uteri: a review. , 1997, Cancer genetics and cytogenetics.

[55]  C. Raetz,et al.  Identification and selective inhibition of an isozyme of steroid 5 alpha-reductase in human scalp. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[56]  Pathological Society of Great Britain and Ireland , 1956 .

[57]  F. Mertens,et al.  Cytogenetic abnormalities in 106 oral squamous cell carcinomas. , 2006, Cancer genetics and cytogenetics.

[58]  Gordon K. Smyth,et al.  limma: Linear Models for Microarray Data , 2005 .

[59]  C. Lundsteen,et al.  Comparative genomic hybridization reveals a recurrent pattern of chromosomal aberrations in severe dysplasia/carcinoma in situ of the cervix and in advanced‐stage cervical carcinoma , 1999, Genes, chromosomes & cancer.